Scinai Immunotherapeutics Ltd. SEC filings SCNI

Scinai Immunotherapeutics Ltd. has 495 filings in SEC EDGAR's recent list, going back to Nov 13, 2014. Its latest annual report, Form 20-F, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on May 15, 2023, covering the quarter ended Mar 31, 2023. The most recent current report (Form 6-K) was filed on Oct 20, 2026. The company's fiscal year ends on December 31.

Form Description Filed Period
20-F Annual report (foreign issuer) Apr 1, 2026 Dec 31, 2025
20-F Annual report (foreign issuer) May 7, 2025 Dec 31, 2024
20-F Annual report (foreign issuer) May 15, 2024 Dec 31, 2023
10-K Annual report Apr 17, 2023 Dec 31, 2022
20-F Annual report (foreign issuer) Mar 28, 2022 Dec 31, 2021
20-F Annual report (foreign issuer) May 13, 2021 Dec 31, 2020
20-F Annual report (foreign issuer) Jun 12, 2020 Dec 31, 2019
20-F Annual report (foreign issuer) Apr 30, 2019 Dec 31, 2018
20-F Annual report (foreign issuer) Apr 30, 2018 Dec 31, 2017
20-F Annual report (foreign issuer) Apr 28, 2017 Dec 31, 2016
20-F Annual report (foreign issuer) Apr 27, 2016 Dec 31, 2015

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
SCNI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Jerusalem, Israel
SEC filer status
Non-accelerated filer
SEC CIK
1611747
Former names
BiondVax Pharmaceuticals Ltd. (until Aug 28, 2023)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.